Deemed Approvals And Legal Risks

Introduction

Deemed approvals refer to situations in which an application, permission, or regulatory proposal is treated as approved because the competent authority has failed to communicate a decision within a legally prescribed period, provided the applicable law expressly establishes such a consequence.

This concept is relevant in biotechnology, pharmaceutical manufacturing, clinical research, environmental clearances, medical devices, genetic engineering, and research institutions. Regulatory authorities generally examine applications to ensure compliance with safety, ethical, environmental, and technical requirements.

However, delays in regulatory decision-making may affect research projects, commercial operations, and scientific innovation. Deemed approval provisions may address such delays, but they also create legal risks when applicants assume that silence automatically means permission.

In biotechnology, this issue is particularly important because unauthorised activities involving biological materials, genetically modified organisms, clinical trials, or experimental medicines may create serious public health and environmental consequences.

Meaning And Legal Nature Of Deemed Approvals

A deemed approval is a legal fiction created by legislation or applicable regulations. It treats an application as approved after a specified period if the prescribed conditions are satisfied and the authority has not issued a decision.

However, three conditions are generally important:

The relevant legislation or regulation must expressly provide for deemed approval.

The application must satisfy the prescribed procedural and substantive requirements.

The statutory period and other conditions for automatic approval must have been fulfilled.

Mere administrative silence does not ordinarily create permission.

For example, if a biotechnology company submits an application for a regulated research activity, it cannot begin the activity merely because the regulatory authority has not responded. It must identify an applicable statutory provision expressly providing for deemed approval.

Legal Framework Governing Deemed Approvals In India

1. General Principles Of Administrative Law

Indian administrative law recognises that statutory authorities must exercise their powers according to the law governing them.

Where legislation establishes a specific decision-making period, authorities are expected to follow that requirement. However, failure to decide within the prescribed period does not automatically create approval unless the statute provides such a consequence.

Articles 14 and 21 of the Constitution also provide relevant safeguards against arbitrary administrative action and unjustified interference with individual rights.

2. New Drugs and Clinical Trials Rules, 2019

The New Drugs and Clinical Trials Rules, 2019, regulate clinical trials and approvals concerning new drugs.

These rules establish procedures for applications, regulatory permissions, ethics committee oversight, and participant protection.

Any deemed approval mechanism must be interpreted according to the precise applicable rule and the nature of the application. Silence should not be treated as permission where the rules do not expressly establish that consequence.

3. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986, provides powers to regulate activities that may affect environmental quality.

Environmental clearance requirements and genetically modified organism regulations may impose specific approval procedures.

A biotechnology company cannot assume that failure to receive a response automatically authorises an environmentally regulated activity.

4. Biological Diversity Act, 2002

The Biological Diversity Act, 2002, as amended, regulates access to biological resources and associated traditional knowledge in specified circumstances.

Where prior approval or intimation is legally required, applicants must comply with the applicable statutory procedure. Administrative delay does not automatically eliminate those requirements.

5. General Data Protection Regulation

Under the GDPR, regulatory approvals and permissions must be distinguished from lawful bases for processing personal data.

An organisation cannot assume that an application or notification relating to data processing has been approved merely because a supervisory authority has not responded, unless a specific legal provision establishes that result.

Major Legal Risks Associated With Deemed Approvals

1. Unauthorised Regulatory Activities

The most significant risk arises when organisations begin regulated activities without obtaining legally required permission.

For example, starting a clinical trial based only on an assumption of deemed approval may result in regulatory action if the applicable rules require express authorisation.

2. Public Health And Biosafety Risks

Biotechnology projects may involve genetically modified organisms, biological samples, experimental medicines, and specialised laboratory procedures. Treating silence as permission may bypass essential safety assessments.

3. Environmental Liability

An organisation that begins an activity without valid environmental authorisation may face suspension, penalties, remediation obligations, or other legal consequences.

4. Contractual And Financial Risks

Companies may invest in equipment, laboratories, and manufacturing facilities based on an incorrect assumption that approval has been granted. If permission is subsequently refused, contractual disputes and financial losses may arise.

5. Administrative And Judicial Challenges

Competitors, affected communities, research participants, and other interested parties may challenge an allegedly unlawful approval or unauthorised activity before the appropriate authority or court.

6. Misrepresentation And Fraud Risks

Submitting inaccurate information or falsely claiming that regulatory approval has been obtained may create additional civil, administrative, or criminal consequences depending on the applicable law.

Relevant Case Laws

1. State of Punjab v. Amar Singh Harika (1966)

The Supreme Court of India examined the legal effectiveness of an administrative dismissal order and the importance of communicating the decision to the affected individual.

Relevance: The decision demonstrates that administrative actions must satisfy applicable legal requirements before producing their intended consequences. It is useful when examining disputes concerning regulatory decisions and official communication, although it does not establish a general rule of deemed approval.

2. Bhavnagar University v. Palitana Sugar Mill Pvt. Ltd. (2003)

The Supreme Court considered the interpretation of statutory provisions concerning land-use planning and regulatory powers.

The judgment emphasised that statutory powers and procedures must be interpreted according to the legislative framework.

Relevance: Biotechnology organisations must follow the specific approval requirements established by applicable legislation. Administrative silence cannot replace statutory permission unless the law expressly provides otherwise.

3. State of Jharkhand v. Ambay Cements (2005)

The Supreme Court emphasised that where a statute prescribes a particular procedure for obtaining a legal benefit or permission, the prescribed requirements must be fulfilled.

Relevance: A biotechnology company seeking regulatory approval must satisfy mandatory statutory conditions. It cannot rely on assumptions of automatic approval when the legislation requires compliance with specific procedures.

4. M.C. Mehta v. Union of India (Oleum Gas Leak Case) (1987)

The Supreme Court developed the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities.

Relevance: Where biotechnology operations involve hazardous activities, an organisation cannot avoid responsibility for resulting harm merely because it believes that an approval was implied or that regulatory authorities failed to respond.

These decisions provide broader administrative and regulatory principles rather than directly establishing a universal doctrine of deemed approval.

Compliance Measures For Biotechnology Organisations

Biotechnology companies, pharmaceutical manufacturers, and research institutions should adopt preventive compliance procedures.

Important measures include:

Identifying the exact statutory provision governing each approval.

Verifying whether deemed approval is expressly permitted.

Maintaining proof of application submission and acknowledgement.

Monitoring statutory decision-making periods.

Obtaining written clarification from the competent authority where necessary.

Avoiding regulated activities until valid authorisation is established.

Maintaining records of regulatory correspondence.

Seeking legal advice before relying on administrative silence.

A regulatory compliance register can help organisations monitor applications, approval conditions, renewal dates, and outstanding regulatory requirements.

Conclusion

Deemed approvals can provide administrative certainty where legislation expressly recognises automatic approval after a prescribed period. However, regulatory silence does not generally constitute legal permission. In biotechnology, incorrectly assuming deemed approval may create serious consequences involving clinical research, biosafety, environmental protection, and public health. Indian judicial decisions concerning statutory interpretation and administrative procedures reinforce the importance of following prescribed legal requirements. Organisations should verify the applicable legislation, maintain regulatory records, and obtain valid authorisation before commencing regulated activities.